SLAM
ANAB icon

Swiss Life Asset Management’s AnaptysBio ANAB Stock Holding History

Swiss Life Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Buy
+3,621
New +$219K ﹤0.01% 1413

Other funds holding ANAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Swiss Life Asset Management's ANAB Position: Q2 2026 in Review

Swiss Life Asset Management opened a new position in AnaptysBio (ANAB) in Q2 2026: 3,621 shares worth $244K. The stake represents ﹤0.01% of the portfolio and ranks #1413 among its holdings.

102 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Swiss Life Asset Management held 3,621 shares of AnaptysBio worth $244K as of Q2 2026.
  • AnaptysBio was a new Swiss Life Asset Management position in Q2 2026.
  • AnaptysBio made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1413 holding.
  • 102 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.